Walleye Trading’s AnaptysBio ANAB Stock Holding History

Walleye Trading’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13,500	Closed	-$219K	–	3935
2019 Q4	$219K	Buy	+13,500	New	+$319K	﹤0.01%	3092

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Walleye Trading's ANAB Position: Q4 2020 in Review

Walleye Trading sold out of AnaptysBio (ANAB) in Q4 2020, closing a stake of 10,500 shares — an estimated $155K sold.

Walleye Trading first reported a position in ANAB in Q1 2019 and held it in 4 quarters. The position peaked at $310K in Q2 2019. 136 funds tracked by Wall St. Rank hold ANAB as of Q4 2020.

Walleye Trading reported no remaining AnaptysBio position as of Q4 2020 after selling out during the quarter.
Walleye Trading sold 10,500 AnaptysBio shares in Q4 2020, an estimated $155K.
Walleye Trading first reported a position in AnaptysBio in Q1 2019 and held it in 4 quarters.
Walleye Trading's AnaptysBio position peaked at $310K in Q2 2019.
136 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2020.

Based on Walleye Trading's 13F filing for Q4 2020, filed 16 Feb 2021.